Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence - Related Studies

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

This study has been completed.

Study NCT00001705. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Melanoma
		Neoplasm Metastasis

2	More general conditions related to this trial
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms, Germ Cell and Embryonal
		Neoplasms, Nerve Tissue
		Neoplastic Processes
		Neuroectodermal Tumors
		Neuroendocrine Tumors
		Nevi and Melanomas
		Pathologic Processes

3	Interventions listed in this trial
		GP100 peptide
		IL-2

4	Sponsors listed in this trial
		National Cancer Institute (NCI)